Home
Live Updates
Japanese Approval Sought for Enfortumab Vedotin Plus Pembrolizumab in Urothelial Cancer : vimarsana.com
Japanese Approval Sought for Enfortumab Vedotin Plus Pembrolizumab in Urothelial Cancer
A sNDA seeking approval of enfortumab vedotin plus pembrolizumab for first-line use in patients with urothelial cancer has been submitted to Japan’s MHLW.
Related Keywords
Japan ,
,
European Medicines Agency ,
Astellas Pharma Inc ,
Japan Ministry Of Health ,
Medicines Agency ,
Enfortumab Vedotin ,
Padcev ,
Pembrolizumab ,
Keytruda ,
Urothelial Cancer ,
Supplemental New Drug Application ,
Ministry Of Health ,
Abour ,
Nd Welfare ,
Ev 302 Keynote A39 Study ,
vimarsana.com © 2020. All Rights Reserved.